<DOC>
	<DOCNO>NCT03009591</DOCNO>
	<brief_summary>Introduction : The common clinical manifestation hemophilia skeletal muscle bleeds , especially hematomas hemarthrosis . Repeated episode joint bleed certain joint , cause progressive joint deterioration . Secondary disorder joint degeneration include : biomechanical alteration , loss range movement periarticular muscle atrophy . Design . A prospective , multicenter longitudinal pilot study evaluate efficacy treatment protocol fascial therapy apply patient hemophilic arthropathy elbow . Aimed : To evaluate safety efficacy physiotherapy treatment fascial therapy patient hemophilic arthropathy elbow Patients : A total 60 patient hemophilia prophylactic treatment recruit inclusion study . Patients recruit 6 center , different region Spain . Intervention : Each session last approximately 50 minute , three physiotherapy session take place period 3 week . The treatment program include 11 maneuver must administer bilaterally : Measuring instrument study variable : goniometric evaluation ( range movement ) ; visual analog scale ( joint pain ) ; Haemophilia Joint Health Score ( joint status ) ; DASH Questionnaire ( functionality upper limb ) ; SF-36 Questionnaire ( perception quality life ) . At time , study allow determine joint bleeding cause applied physiotherapy treatment . Expected result : First , intend demonstrate safety physiotherapy technique patient hemophilia . Likewise , improvement perception elbow pain joint mobility expect . An improved functionality upper limb also foreseen , enhanced perception quality life patient .</brief_summary>
	<brief_title>Fascial Therapy Elbow Hemophilic Arthropathy</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>Patients diagnose hemophilia A B Patients adult ( 18 year ) Patients diagnose hemophilic arthropathy elbow ( clinical assessment Hemophilia Joint Health Score ) Patients pn prophylactic treatment FVIII / FIX concentrate . Patients without ambulation ability Patients inhibitor Patients neurological cognitive alteration impede comprehension questionnaire physical test Patients sign informed consent document .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hemophilia</keyword>
	<keyword>Elbow</keyword>
	<keyword>Arthropathy</keyword>
	<keyword>Joint pain</keyword>
	<keyword>Range motion</keyword>
	<keyword>Myofascial technique</keyword>
	<keyword>Safety patient</keyword>
	<keyword>Quality life</keyword>
	<keyword>Functionality</keyword>
</DOC>